Could This Drug Help Cancer Patients Live Longer?

Claims are swirling after results from a Phase III clinical trial.

Results from a Phase III clinical trial have Bayer AG saying their drug can extend the lives of liver cancer patients, according to Reuters.

The drug the company is speaking of is called Regorafenib.

And according to Reuters, the company's next move is to file for regulatory approval of the oncology compound.

Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026